These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36071350)

  • 21. An Exploration of Factors Affecting
    Ruzycki CA; Martin AR; Finlay WH
    J Aerosol Med Pulm Drug Deliv; 2019 Dec; 32(6):405-417. PubMed ID: 31418632
    [No Abstract]   [Full Text] [Related]  

  • 22. Design of spray dried insulin microparticles to bypass deposition in the extrathoracic region and maximize total lung dose.
    Ung KT; Rao N; Weers JG; Huang D; Chan HK
    Int J Pharm; 2016 Sep; 511(2):1070-9. PubMed ID: 27480399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aerosolization characteristics of dry powder inhaler formulations for the excipient enhanced growth (EEG) application: effect of spray drying process conditions on aerosol performance.
    Son YJ; Worth Longest P; Hindle M
    Int J Pharm; 2013 Feb; 443(1-2):137-45. PubMed ID: 23313343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of generation time on spray aerosol transport and deposition in models of the mouth-throat geometry.
    Worth Longest P; Hindle M; Das Choudhuri S
    J Aerosol Med Pulm Drug Deliv; 2009 Jun; 22(2):67-83. PubMed ID: 18956949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro tests for aerosol deposition. III: effect of inhaler insertion angle on aerosol deposition.
    Delvadia RR; Longest PW; Hindle M; Byron PR
    J Aerosol Med Pulm Drug Deliv; 2013 Jun; 26(3):145-56. PubMed ID: 23025452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro dose comparison of Respimat
    Ciciliani AM; Langguth P; Wachtel H
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1565-1577. PubMed ID: 28603412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In Vitro Tests for Aerosol Deposition. IV: Simulating Variations in Human Breath Profiles for Realistic DPI Testing.
    Delvadia RR; Wei X; Longest PW; Venitz J; Byron PR
    J Aerosol Med Pulm Drug Deliv; 2016 Apr; 29(2):196-206. PubMed ID: 26447531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In-vitro and particle image velocimetry studies of dry powder inhalers.
    Dos Reis LG; Chaugule V; Fletcher DF; Young PM; Traini D; Soria J
    Int J Pharm; 2021 Jan; 592():119966. PubMed ID: 33161040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of enhanced condensational growth (ECG) for controlled respiratory drug delivery in a mouth-throat and upper tracheobronchial model.
    Hindle M; Longest PW
    Pharm Res; 2010 Sep; 27(9):1800-11. PubMed ID: 20454837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of a general in vitro approach for prediction of total lung deposition in healthy adults for pharmaceutical inhalation products.
    Olsson B; Borgström L; Lundbäck H; Svensson M
    J Aerosol Med Pulm Drug Deliv; 2013 Dec; 26(6):355-69. PubMed ID: 23421897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of Bio-relevant Mouth-Throat Models for Characterization of Metered Dose Inhalers.
    Kaviratna A; Tian G; Liu X; Delvadia R; Lee S; Guo C
    AAPS PharmSciTech; 2019 Feb; 20(3):130. PubMed ID: 30815748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Initial Development of an Air-Jet Dry Powder Inhaler for Rapid Delivery of Pharmaceutical Aerosols to Infants.
    Howe C; Hindle M; Bonasera S; Rani V; Longest PW
    J Aerosol Med Pulm Drug Deliv; 2021 Feb; 34(1):57-70. PubMed ID: 32758026
    [No Abstract]   [Full Text] [Related]  

  • 33. Computational investigation of particle penetration and deposition pattern in a realistic respiratory tract model from different types of dry powder inhalers.
    Kim YH; Li DD; Park S; Yi DS; Yeoh GH; Abbas A
    Int J Pharm; 2022 Jan; 612():121293. PubMed ID: 34808267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical relevance of dry powder inhaler performance for drug delivery.
    Demoly P; Hagedoorn P; de Boer AH; Frijlink HW
    Respir Med; 2014 Aug; 108(8):1195-203. PubMed ID: 24929253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of in vitro deposition of pharmaceutical aerosols in an idealized child throat with in vivo deposition in the upper respiratory tract of children.
    Ruzycki CA; Golshahi L; Vehring R; Finlay WH
    Pharm Res; 2014 Jun; 31(6):1525-35. PubMed ID: 24395403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors Determining In Vitro Lung Deposition of Albuterol Aerosol Delivered by Ventolin Metered-Dose Inhaler.
    Biswas R; Hanania NA; Sabharwal A
    J Aerosol Med Pulm Drug Deliv; 2017 Aug; 30(4):256-266. PubMed ID: 28157430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validating CFD Predictions of Pharmaceutical Aerosol Deposition with In Vivo Data.
    Tian G; Hindle M; Lee S; Longest PW
    Pharm Res; 2015 Oct; 32(10):3170-87. PubMed ID: 25944585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental measurements of particle deposition in three proximal lung bifurcation models with an idealized mouth-throat.
    Zhang Y; Finlay WH
    J Aerosol Med; 2005; 18(4):460-73. PubMed ID: 16379621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterizing the Effects of Nasal Prong Interfaces on Aerosol Deposition in a Preterm Infant Nasal Model.
    Bass K; Momin MAM; Howe C; Aladwani G; Strickler S; Kolanjiyil AV; Hindle M; DiBlasi RM; Longest W
    AAPS PharmSciTech; 2022 Apr; 23(5):114. PubMed ID: 35441324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A simple mechanistic model of deposition of water-soluble aerosol particles in the mouth and throat.
    Mitsakou C; Mitrakos D; Neofytou P; Housiadas C
    J Aerosol Med; 2007; 20(4):519-29. PubMed ID: 18158723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.